Kontour (Xi'an) Medical Technology Co., Ltd. (SHA:688314)
China · Delayed Price · Currency is CNY 56.21
+6.29 (12.60%)
Apr 1, 2026, 3:00 PM CST
SHA:688314 Revenue
In the year 2025, Kontour (Xi'an) Medical Technology had annual revenue of 351.08M CNY with 9.05% growth. Kontour (Xi'an) Medical Technology had revenue of 99.99M in the quarter ending December 31, 2025, with 22.19% growth.
Revenue
351.08M
Revenue Growth
+9.05%
P/S Ratio
13.01
Revenue / Employee
1.13M
Employees
322
Market Cap
4.57B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 351.08M | 29.13M | 9.05% |
| Dec 31, 2024 | 321.95M | 46.92M | 17.06% |
| Dec 31, 2023 | 275.03M | 35.08M | 14.62% |
| Dec 31, 2022 | 239.95M | 27.40M | 12.89% |
| Dec 31, 2021 | 212.55M | 48.47M | 29.54% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jan 1, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jan 1, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Wuhan Huakang Century Clean Technology | 2.06B |
| Guangdong Biolight Meditech | 1.05B |
| Shanghai Kinetic Medical | 1.02B |
| Zhejiang Orient Gene Biotech | 958.99M |
| Hangzhou AGS MedTech | 597.21M |
| Ningbo David Medical Device | 516.76M |
| Nanjing Medlander Medical Technology | 431.59M |
| Wuhan Easy Diagnosis Biomedicine | 351.25M |